We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidant Says FDA Warning Letter Concerns Will Be Addressed
Guidant Says FDA Warning Letter Concerns Will Be Addressed
February 2, 2006
Guidant said last month it is on track to address the FDA’s warning letter concerns about a wide-range of current good manufacturing practice (cGMP) issues including electronic records and signatures.